Fatigue News and Research

RSS

Twitter can indicate community's psychological well being, predict rates of heart disease

Twitter has broken news stories, launched and ended careers, started social movements and toppled governments, all by being an easy, direct and immediate way for people to share what's on their minds. Researchers from the University of Pennsylvania have now shown that the social media platform has another use: Twitter can serve as a dashboard indicator of a community's psychological well being and can predict rates of heart disease.

22 Jan 2015

MedExpress physicians offer appropriate option to assess, treat flu or cold symptoms

As flu season progresses, patients across the country continue to seek care for flu and illness symptoms at a variety of health care locations. From doctors' offices to emergency rooms, many patients find it difficult to determine the best option based on their symptoms. MedExpress physicians remind patients, that in many cases, urgent care centers offer a convenient, appropriate option for the assessment and treatment of non-severe flu or cold symptoms.

21 Jan 2015

New study finds link between dyspareunia and mode of delivery

Operative birth is associated with persisting pain during or after sexual intercourse, known as dyspareunia, suggests a new study published today (21 January) in BJOG: An International Journal of Obstetrics and Gynaecology.

21 Jan 2015

Penn State researchers explore benefits of beet juice

Athletes who down beet juice before exercising to increase blood flow and improve performance may be surprised at the results of a recent study conducted at Penn State's Noll Laboratory. While beetroot juice rich in nitrates did not enhance muscle blood flow or vascular dilation during exercise, researchers found that it did "de-stiffen" blood vessels under resting conditions, potentially easing the workload of the heart.

20 Jan 2015

Nonmotor symptoms cluster in Parkinson’s disease patients

Nonmotor symptoms tend to appear in specific clusters in patients with Parkinson’s disease and often predate the onset of motor symptoms, research shows.

16 Jan 2015

GenSpera reports encouraging results from mipsagargin Phase II study for HCC treatment

GenSpera Inc. today announced the encouraging results of a Phase II study of mipsagargin (G-202), an investigational agent for the treatment of hepatocellular carcinoma (HCC).

16 Jan 2015

AbbVie gets European Commission's approval to market VIEKIRAX + EXVIERA for HCV treatment

AbbVie announced that the European Commission has granted marketing authorizations for its all-oral, short-course, interferon-free treatment of VIEKIRAX (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA (dasabuvir tablets). The treatment has been approved with or without ribavirin (RBV) for patients with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection, including those with compensated liver cirrhosis, HIV-1 co-infection, patients on opioid substitution therapy and liver transplant recipients.

16 Jan 2015

Therapy Box releases app that allows people with limited vocal ability to use own voices

The UK-based Therapy Box has released the first app that allows people who have limited vocal ability or are losing their voices due to ALS and other disabling conditions to replace generic text-to-speech synthesis with a synthesizer based on their own voice. The app breaks new ground via the integration of ModelTalker, a program developed by Tim Bunnell, PhD and colleagues at the Nemours Speech Research Laboratory in Wilmington, DE.

15 Jan 2015

Reducing fears key to success of CBT or GET in people with chronic fatigue syndrome

Reducing fears that exercise or activity will make symptoms worse is one of the most important factors determining the success of cognitive behaviour therapy (CBT) or graded exercise therapy (GET) in reducing fatigue and improving physical function in people with chronic fatigue syndrome (CFS), according to new analysis of data from the PACE trial, reported in The Lancet Psychiatry journal.

14 Jan 2015

Research findings may lead to new treatment for hypothyroidism

An international research team led by physician-scientists at Rush University Medical Center have gained new insights into hypothyroidism - a condition affecting about 10 million people in the U.S. - that may lead to new treatment protocols for the disease, particularly among the approximately 15 percent of patients for whom standard treatments are less effective.

14 Jan 2015

Lack of information increases depression risk in people recovering from stroke

People recovering from a stroke and living at home have generally a higher risk of suffering from depression. According to researchers lack of information is often a major concern for patients and this frequently contributes to their depression. This is the result of a new study from health sociologists of the University of Luxembourg.

12 Jan 2015

Two new ODYSSEY trials meet primary efficacy endpoints

Regeneron Pharmaceuticals, Inc. and Sanofi today announced that two new ODYSSEY trials, which are the first Phase 3 trials to assess alirocumab administered every four weeks, met their primary efficacy endpoints.

9 Jan 2015

Testosterone therapy suppresses some advanced prostate cancers, find Johns Hopkins scientists

In a surprising paradox, the male hormone testosterone, generally thought to be a feeder of prostate cancer, has been found to suppress some advanced prostate cancers and also may reverse resistance to testosterone-blocking drugs used to treat prostate cancer.

8 Jan 2015

FDA receives Actavis' NDA resubmission for cariprazine

Actavis plc (NYSE: ACT) and Gedeon Richter Plc. today announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of Actavis' New Drug Application (NDA) resubmission for its atypical antipsychotic cariprazine, a potent dopamine D3/D2 receptor partial agonist with preferential binding to D3 receptors.

6 Jan 2015

Making New Year's resolution to control diabetes

José Rodriguez often skipped breakfast and lunch only to eat a large dinner at the end of the day. Despite his erratic eating habits, Mr. Rodriguez thought he was healthy until a routine blood test revealed he had type 2 diabetes.

2 Jan 2015

Protein Sciences earns Frost & Sullivan 2013 Global New Product Innovation Award

Based on its recent analysis of the influenza vaccines market, Frost & Sullivan recognises Protein Sciences with the 2013 Global New Product Innovation Award. Flublok is the world's first recombinant protein vaccine for the prevention of seasonal influenza disease to gain U.S. FDA approval.

29 Dec 2014

Negative health effects of severe obesity

The negative health effects of severe obesity are very well known and have been thoroughly documented, yet obesity levels in the United States continue to remain stubbornly high. Many of these repercussions are life threatening and include heart attack, stroke, and a greatly increased chance of developing cancer.

27 Dec 2014

FDA approves Novo Nordisk’s weight loss injection, Saxenda

Novo Nordisk today announced that the Food and Drug Administration (FDA) has approved the new drug application (NDA) for Saxenda® (liraglutide [rDNA origin] injection), the first once-daily glucagon-like peptide-1 (GLP-1) receptor agonist for chronic weight management.

25 Dec 2014

Long-term axitinib in RCC effective with ‘controllable’ toxicities

Axitinib treatment is effective in the long-term in Japanese patients with metastatic renal cell carcinoma and has manageable toxicity, a phase II study suggests.

19 Dec 2014

Older adults participating in hospital-based exercise program report less pain, stiffness and fatigue

It may seem counterintuitive, but exercise can be beneficial for people suffering from arthritis and other muscle and joint conditions. A new study at Hospital for Special Surgery finds that older adults experienced less pain, reduced stiffness and less fatigue after participating in a hospital-based exercise program.

16 Dec 2014

Fatigue News and Research

Twitter can indicate community's psychological well being, predict rates of heart disease

MedExpress physicians offer appropriate option to assess, treat flu or cold symptoms

New study finds link between dyspareunia and mode of delivery

Penn State researchers explore benefits of beet juice

Nonmotor symptoms cluster in Parkinson’s disease patients

GenSpera reports encouraging results from mipsagargin Phase II study for HCC treatment

AbbVie gets European Commission's approval to market VIEKIRAX + EXVIERA for HCV treatment

Therapy Box releases app that allows people with limited vocal ability to use own voices

Reducing fears key to success of CBT or GET in people with chronic fatigue syndrome

Research findings may lead to new treatment for hypothyroidism

Lack of information increases depression risk in people recovering from stroke

Two new ODYSSEY trials meet primary efficacy endpoints

Testosterone therapy suppresses some advanced prostate cancers, find Johns Hopkins scientists

FDA receives Actavis' NDA resubmission for cariprazine

Making New Year's resolution to control diabetes

Protein Sciences earns Frost & Sullivan 2013 Global New Product Innovation Award

Negative health effects of severe obesity

FDA approves Novo Nordisk’s weight loss injection, Saxenda

Long-term axitinib in RCC effective with ‘controllable’ toxicities

Older adults participating in hospital-based exercise program report less pain, stiffness and fatigue

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News